Community Based Organizations

This video educates viewers on what the PrEP-to-Need Ratio is and how to properly use it to evaluate health equity.

This video walks through AIDSVu Location Profiles -- interactive, user-friendly summaries of HIV data for various locations across the U.S., including cities, counties, states, and regions. These profiles provide insights into HIV prevalence, new diagnoses, mortality, and more, helping users understand the impact of HIV in their communities.

This webinar recording discusses tests for TB and drug resistance. It also reviews TB screening, diagnosis, treatment monitoring, and more. 

This webpage outlines the importance of disaster preparedness for people with HIV. Natural disasters—such as hurricanes, tornadoes, tsunamis, and wildfires—can displace anyone, disrupting access to critical HIV medicines and care. It emphasizes the need for individuals with HIV to plan ahead to maintain treatment continuity, protect their health, and reduce the risk of transmission, including steps to connect with new healthcare providers if displaced.

This fact sheet discusses that navigating prescription drug access for clients can present many challenges and barriers. NASTAD is committed to developing and maintaining resources highlighting initiatives aiming to maximize affordable access to essential medicines, including programs for uninsured/underinsured individuals and cost-sharing assistance for insured individuals contending with out-of-pocket spending.

This fact sheet reports over 52,000 cases of chlamydia, gonorrhea, and syphilis, including a rise in congenital syphilis and significant racial disparities. It emphasizes routine testing, condom use, and partner communication to prevent and treat STIs statewide.

This webpage explains that persistent high-risk HPV—especially type 16—is a leading cause of oropharyngeal cancer, accounting for around 70% of U.S. throat cancers, and highlights prevention strategies like vaccination, sexual health practices, and regular screenings.

This fact sheet outlines that herpes simplex virus (HSV‑1 and HSV‑2) is a common, lifelong infection causing oral or genital blisters, transmitted via skin-to-skin or saliva contact—even when asymptomatic—and managed through antiviral treatment and preventive measures. It emphasizes that many individuals are unaware of their infection and underscores the role of condoms and suppressive therapy in reducing symptom recurrence and transmission.

This information sheet outlines how individuals can take a two‑pill (200 mg) dose of doxycycline within 24–72 hours after condomless oral, anal, or vaginal sex to significantly reduce the risk of syphilis, gonorrhea, and chlamydia. It provides clear dosing instructions, timing guidance, and encourages regular STI screening and care coordination.

This report describes a newborn diagnosed with congenital syphilis, born to an adolescent mother without routine prenatal care. Despite initial diagnostic challenges, timely testing and treatment led to a positive outcome in accordance with national guidelines.